BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21049561)

  • 61. Hepatocellular carcinoma tumour burden score to stratify prognosis after resection.
    Tsilimigras DI; Moris D; Hyer JM; Bagante F; Sahara K; Moro A; Paredes AZ; Mehta R; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Aldrighetti L; Endo I; Sasaki K; Rodarte AI; Aucejo FN; Pawlik TM
    Br J Surg; 2020 Jun; 107(7):854-864. PubMed ID: 32057105
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liver resection for hepatocellular carcinoma: personal experiences in a series of 1330 consecutive cases in China.
    Li J; Huang L; Yan J; Qiu M; Yan Y
    ANZ J Surg; 2018 Oct; 88(10):E713-E717. PubMed ID: 29363237
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan.
    Minagawa M; Ikai I; Matsuyama Y; Yamaoka Y; Makuuchi M
    Ann Surg; 2007 Jun; 245(6):909-22. PubMed ID: 17522517
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment.
    Vauthey JN; Ribero D; Abdalla EK; Jonas S; Bharat A; Schumacher G; Lerut J; Chapman WC; Hemming AW; Neuhaus P
    J Am Coll Surg; 2007 May; 204(5):1016-27; discussion 1027-8. PubMed ID: 17481532
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.
    Huo TI; Hsia CY; Huang YH; Lin HC; Lee PC; Lui WY; Chiang JH; Chiou YY; Loong CC; Lee SD
    J Clin Gastroenterol; 2009 Sep; 43(8):773-81. PubMed ID: 19262404
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The survival strength of younger patients in BCLC stage 0-B of hepatocellular carcinoma: basing on competing risk model.
    Yan H; Wang X; Liu X; Wang P; Yu L; Zhou D; Yang Z
    BMC Cancer; 2022 Feb; 22(1):185. PubMed ID: 35180841
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Barcelona Clinic Liver Cancer staging system and survival of untreated hepatocellular carcinoma in a hepatitis B virus endemic area.
    Lee JH; Kim HY; Kim YJ; Yoon JH; Chung JW; Lee HS
    J Gastroenterol Hepatol; 2015 Apr; 30(4):696-705. PubMed ID: 25250761
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of eight different clinical staging systems associated with overall survival of chinese patients with hepatocellular carcinoma.
    Zhao JJ; Yan T; Zhao H; Zhou JG; Huang Z; Zhang YF; Li Y; Li ZY; Bi XY; Cai JQ
    Chin Med J (Engl); 2015 Feb; 128(3):316-21. PubMed ID: 25635426
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Evaluation of the new AJCC staging system for resectable hepatocellular carcinoma.
    Cheng CH; Lee CF; Wu TH; Chan KM; Chou HS; Wu TJ; Yu MC; Chen TC; Lee WC; Chen MF
    World J Surg Oncol; 2011 Sep; 9():114. PubMed ID: 21958080
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona Clinic Liver Cancer stages: a multicentre study.
    Vitale A; Burra P; Frigo AC; Trevisani F; Farinati F; Spolverato G; Volk M; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Cillo U;
    J Hepatol; 2015 Mar; 62(3):617-24. PubMed ID: 25450706
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A modified TNM-7 staging system to better predict the survival in patients with hepatocellular carcinoma after hepatectomy.
    Huang J; Zhang Y; Peng Z; Gao H; Xu L; Jiao LR; Chen M
    J Cancer Res Clin Oncol; 2013 Oct; 139(10):1709-19. PubMed ID: 23982274
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naïve patients with hepatocellular carcinoma.
    Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Park MS; Kim EH; Seong J; Lee DY; Han KH
    Liver Int; 2012 Aug; 32(7):1120-7. PubMed ID: 22524688
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modified Japan Integrated Staging is currently the best available staging system for hepatocellular carcinoma patients who have undergone hepatectomy.
    Nanashima A; Sumida Y; Abo T; Shindou H; Fukuoka H; Takeshita H; Hidaka S; Tanaka K; Sawai T; Yasutake T; Nagayasu T; Omagari K; Mine M
    J Gastroenterol; 2006 Mar; 41(3):250-6. PubMed ID: 16699859
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A comparative study of pathological staging systems in predicting recurrent hepatocellular carcinoma after liver transplantation.
    Okuno T; Tsuruyama T; Haga H; Ueda M; Takada Y; Maetani Y; Manabe T; Tamaki K
    J Hepatobiliary Pancreat Surg; 2009; 16(6):802-7. PubMed ID: 19399360
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 76. NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging.
    Su TH; Liao SH; Hong CM; Liu CJ; Tseng TC; Liu CH; Yang HC; Chen PJ; Chen DS; Chen CL; Adhoute X; Bourlière M; Kao JH
    J Gastroenterol Hepatol; 2019 Dec; 34(12):2179-2186. PubMed ID: 31062879
    [TBL] [Abstract][Full Text] [Related]  

  • 77. BCLC stage B is a better designation for single large hepatocellular carcinoma than BCLC stage A.
    Jung YK; Jung CH; Seo YS; Kim JH; Kim TH; Yoo YJ; Kang SH; Yim SY; Suh SJ; An H; Yim HJ; Yeon JE; Byun KS; Um SH
    J Gastroenterol Hepatol; 2016 Feb; 31(2):467-74. PubMed ID: 26332049
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort.
    Adhoute X; Pénaranda G; Raoul JL; Edeline J; Blanc JF; Pol B; Campanile M; Perrier H; Bayle O; Monnet O; Beaurain P; Muller C; Castellani P; Le Treut YP; Bronowicki JP; Bourlière M
    World J Gastroenterol; 2017 Apr; 23(14):2545-2555. PubMed ID: 28465639
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of 10 prognostic staging systems in patients with advanced hepatocellular carcinoma.
    Wang L; Xian Y; Yang Z
    J BUON; 2019; 24(1):150-157. PubMed ID: 30941964
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Edmondson-Steiner grading increases the predictive efficiency of TNM staging for long-term survival of patients with hepatocellular carcinoma after curative resection.
    Zhou L; Rui JA; Ye DX; Wang SB; Chen SG; Qu Q
    World J Surg; 2008 Aug; 32(8):1748-56. PubMed ID: 18493820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.